Skip to content

Pfizer PFE Total Current Assets

Total Current Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$28.58B-14.0%
Eli Lilly logo
Eli LillyLLY
$54.84B+32.9%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$59.77B+9.7%
Merck & Co. logo
Merck & Co.MRK
$35.02B-1.4%
Amgen logo
AmgenAMGN
$31.48B+16.9%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$2.49B-3.3%

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$143.91B+4.2%
Enterprise value$206.58B+4.2%
P/E11.9×
P/S2.3×+0.1×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's total current assets?
Pfizer (PFE) reported total current assets of $42.82B in Q1 2026.
How has Pfizer's total current assets changed year-over-year?
Pfizer's total current assets decreased by 6.6% year-over-year, from $45.86B to $42.82B.
What is the long-term trend for Pfizer's total current assets?
Over 5 years (2020 to 2025), Pfizer's total current assets has grown at a 4.1% compound annual growth rate (CAGR), from $35.07B to $42.9B.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.